Read indepth magazine
The World’s Most Talked-About Superyacht Continues Turning Heads
As the world’s largest sailing yacht and a regular fixture at the most exclusive Mediterranean destinations, KORU continues to set new benchmarks for innovation, healthcare, and sustainability. Her recent appearances at high-profile events, including the Cannes Film Festival and this week’s Monaco Grand Prix, have only cemented her status as a modern icon of the superyacht world. This summer, with her starring role in the Bezos-Sánchez wedding; KORU is not just a marvel of engineering and design, she’s the stage for an event that perfectly captures the intersection of celebrity, luxury, and maritime excellence.
But the KORU name is making waves beyond the water as well: KORU Medical Systems is transforming patient care globally, with its cutting-edge infusion technology now supporting tens of thousands of patients at home. Whether gracing beautiful ports or transforming patient care, KORU continues to capture global attention and redefine what’s possible.
As the world’s largest sailing yacht, KORU has spent 2025 cementing her reputation as the ultimate symbol of luxury and innovation on the water. Her towering masts and elegant silhouette have become iconic sights in Monaco, Capri, and along the Côte d’Azur, where she’s frequently accompanied by her support vessel, Abeona. This spring, KORU’s high-profile appearances at the Monaco Grand Prix earlier this week and Cannes Film Festival have drawn admiration from yachting enthusiasts and industry insiders alike, showcasing her seamless blend of classic maritime tradition and contemporary design.
This summer, KORU will take centre stage as the venue for the highly anticipated Bezos-Sánchez wedding in Venice; an event that perfectly captures the intersection of celebrity culture, luxury lifestyle, and maritime excellence.
Meanwhile, KORU Medical Systems is making headlines with its innovative Freedom Infusion System™, now supporting over 45,000 patients worldwide in managing their treatments from home. This system, FDA-cleared for subcutaneous administration of immunoglobulins, is transforming the way patients receive care, offering freedom, comfort, and improved quality of life.
The start of 2025 has seen extraordinary demand for KORU’s home healthcare solutions in both the US and international markets, reflecting a broader shift toward home-based therapies. In response, KORU Medical Systems has raised its financial outlook, accelerated investments in next-generation product development, and announced strategic collaborations—including a new agreement to develop an advanced subcutaneous immunoglobulin infusion system in partnership with a major pharmaceutical company and SCHOTT Pharma. The company is also expanding into Japan and advancing clinical trials for new drug indications, further solidifying its leadership in patient-centric innovation.
Whether commanding attention in the world’s most exclusive harbors or transforming lives through medical technology, KORU stands as a leader in premium experiences and patient-focused solutions. As 2025 unfolds, both the legendary superyacht and the pioneering medical company are proving that true excellence knows no boundaries; delivering sophistication, innovation, and life-changing impact wherever their journeys lead next.